1100 reps selling Vyvanse - annual sales $300m - this is a final throw of the dice. Trying to sell Vyvanse against a generic AXR is not going to be easy going forward. How they need to get the deaths data of ODs caused by AXR and Vyvanse. Vyvanse should be zero if the Carrierwave technology works. Animals have survived unscathed after taking 100 Vyvanse tablets. So anyone volunteering for the human trial?